In summary, our results raise the possibility that IL‐34 in the lymphoma tissues of DLBCL patients does not directly act on DLBCL cells but recruits monocytes, leading to the higher number of macrophages in the tissues and poor prognosis of patients. Here, IL34 is linked to diffuse large B-cell lymphoma.